Skip to main content
Clinical Trials/NCT05721157
NCT05721157
Completed
Not Applicable

Osteoporotic Precisely Screening Using Chest Radiograph and Artificial Neural Network (OPSCAN): a Randomized Controlled Trial

National Defense Medical Center, Taiwan1 site in 1 country4,912 target enrollmentJanuary 1, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Osteoporosis
Sponsor
National Defense Medical Center, Taiwan
Enrollment
4912
Locations
1
Primary Endpoint
newly diagnosed with osteoporosis
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Artificial Intelligence-assisted Diagnosis and Prognostication in Osteoporosis Using Chest X-ray

Registry
clinicaltrials.gov
Start Date
January 1, 2023
End Date
June 30, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
National Defense Medical Center, Taiwan
Responsible Party
Principal Investigator
Principal Investigator

Chin Lin

Associate Professor

National Defense Medical Center, Taiwan

Eligibility Criteria

Inclusion Criteria

  • Patients recieved at least 1 chest X-ray examination in 2022
  • More than 66% chest X-ray identified as high risk of osteoporosis by AI-CXR

Exclusion Criteria

  • Patients with history of at least 1 dual energy x-ray absorptiometry (DXA)
  • Patients with history of osteoporosis or osteoportic fracture
  • Patients recieved prescription anti-osteoporotic treatment (excluding vitamin D or calcium)
  • Patients died before 01 Jan 2023

Outcomes

Primary Outcomes

newly diagnosed with osteoporosis

Time Frame: Within 180 days

After performing an chest X-ray, the osteoporosis was followed.

Secondary Outcomes

  • initiation of DXA examination(Within 180 days)
  • initiation of anti-osteoporotic treatment(Within 180 days)

Study Sites (1)

Loading locations...

Similar Trials